HomeDSGN • NASDAQ
add
Design Therapeutics Inc
Previous close
$4.50
Day range
$4.37 - $4.55
Year range
$1.94 - $8.31
Market cap
249.14M USD
Avg Volume
337.22K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 12.83M | -36.37% |
Net income | -11.10M | 42.44% |
Net profit margin | — | — |
Earnings per share | -0.20 | 42.86% |
EBITDA | -14.26M | 33.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 270.69M | -14.17% |
Total assets | 278.79M | -14.15% |
Total liabilities | 9.24M | -22.55% |
Total equity | 269.56M | — |
Shares outstanding | 56.50M | — |
Price to book | 0.94 | — |
Return on assets | -12.67% | — |
Return on capital | -13.02% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -11.10M | 42.44% |
Cash from operations | -12.44M | 28.61% |
Cash from investing | 20.62M | 4.47% |
Cash from financing | 20.00K | — |
Net change in cash | 8.20M | 255.00% |
Free cash flow | -8.83M | 16.90% |
About
Founded
2017
Headquarters
Website
Employees
57